26.02.2013 Views

IsiZulu - Treatment Action Campaign

IsiZulu - Treatment Action Campaign

IsiZulu - Treatment Action Campaign

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

Imithi<br />

yesikhathi esizayo<br />

Emva kwamashumi eminyaka enqubekela phambili encane, imithi emisha<br />

ye-TB isisendleleni ekugcineni. Kodwa-ke, ezinye izinselele zizodinga ukuthi<br />

ngaphambi kokuba le mithi ifinyelele emtholampilo wangakini.<br />

Amakhulunyaka esifo sofuba silokhu singelapheki.<br />

Kwase kuthi, phakathi kweminyaka yo-1940 no-1970<br />

ukutholakala kwama-antibhayothiki amasha kanye<br />

nokwelashwa ngenhlanganisela kwashintsha<br />

yonke into. Sasinemithi, ngakho-ke kwakuyindaba<br />

yesikhathi nje ukuthi siyihambise futhi siyisebenzise<br />

ngendlela elungile. Ngeshwa lokhu kulula ukukusho<br />

kunokukwenza.<br />

Ngemuva kuka-1963, lapho kwakutholakala ikilasi Elisha<br />

lemithi ye-TB, ukwenziwa kwemithi emisha kwabe<br />

sekuma ukwenziwa kwemithi emisha. Kwakungesikho<br />

nje ngeminyaka yo-1990, lapho ukuvela kokungazweli<br />

emithini kwe-TB (DR-TB) kwashayisana nobhubhane<br />

lwe-HIV e-United States naseYurophu, abacwaningi<br />

kanye nezinkampani ezenza imithi zavuselela uthando<br />

lwazo lokwenza imithi engcono ye-TB .<br />

Kusukela ngalesi sikhathi ucwaningo lokwelashwa<br />

kwe-TB seluvuseleleke kabusha. Manje sesinemithi<br />

emisha esendleleni ezayo eshumini leminyaka.<br />

Izinhlanganisela eziyisithpha ezivela emakilasini<br />

emithi evele ikhona nemisha iyahlolwa ezinhlolweni<br />

zokwelapha, okwamanje nezifundo zangaphambi<br />

kokwelashwa . Imithi esivele ikhona ebisetshenziswa<br />

ngaphandle kwelebuli (ngamanye amazwi, izinhloso<br />

ezingagunyazelwe) ukwelapha i-TB sezihloselwe<br />

futhi ukuze zifinyeze ubude bokwelapha, ukunciphisa<br />

imiphumela elimazayo, nokwenza ngcono imiphumela<br />

yokwelapha.<br />

Izinhlanganisela eziqhubeke kakhulu zokwelapha<br />

yi-TMC207 (i-bedaquiline esandokuqanjwa kabusha)<br />

evela kwa-Tibotec kanye ne-OPC-67683 (i-delamanid<br />

eqanjwe kabusha) evela kwa-Otsuka Pharmaceuticals.<br />

Zombili izinhlanganisela zisesigabeni esesihambe<br />

kakhulu zezinhlolo zokwelapha. Onyakeni, izinkampani<br />

kulindeleke ukuthi zifune imvume yokusebenzisa le mithi<br />

ekwelapheni i-DR-TB.<br />

Injabulo ngalezi zinhlanganisela iqedwa ukukhathazeka<br />

ngokuthola imvume yokulawula emhlabeni jikelele<br />

kungenzeka kube inselele. Kuncike ekutheni amazwe<br />

aziguqula kanjani izidingo zawo zokulawula, amandla<br />

okuxilonga, kanye nezinhlelo zokwelapha i-DR-TB, le<br />

mithi ingathatha iminyaka ukuthi ibe khona jikelele<br />

emazweni lapho i-TB iwububhane khona.<br />

TMC207<br />

I-TNV207 seyiqhubeke kakhulu nokwenziwa, ngakhoke<br />

onke mehlo aseku-Tibotec. Inkampani seyiqalile<br />

uhlelo lokusebenzisa ukuzwelana nokwandisa<br />

uhlolo lokufinyelela ekufinyeleleni kwangaphambi<br />

kokugunyazwa ezigulini ezinokhetho lokwelashwa<br />

olunomkhawulo noma ezingenamuthi wokwelashwa.<br />

Lezi zinhlolo zezinhlelo bezisetshenziselwa<br />

izidambisigciwane kanye nemithi yomdlavuza. Kodwake,<br />

akukho muthi we-TB oke wenziwa ukuthi utholakale<br />

ngale ndlela. I-TMC207 ngakho-ke isewudaba lokuhlolwa<br />

ukuqinisekisa ukufinyelela okunokwenzeka kusheshe<br />

emuthini owethembisayo ngesikhathi kuqinisekiswa<br />

futhi ukuthi usetshenziswa ngendlela<br />

efanele.<br />

Ukukhathazeka ukuthi uma<br />

izinhlanganisela zisetshenziswa<br />

ngendlela engafanele – nemithi<br />

ehambisanayo embalwa esebenza<br />

ngempumelelo – kuzoba nezinhlobo<br />

ezintsha zokumelana nemithi ze-TB<br />

ezingavela ngokushesha. Lokhu<br />

kungabeka umkhawulo emtheleleni<br />

wesikhathi eside wananoma<br />

yimuphi umuthi obhubhaneni.<br />

Kudingeka sizivume lezi zinselele<br />

ndawonye nesidingo esiphuthumayo<br />

sokuqinisekisa ukufinyelela emithini<br />

Siyayidinga i-TMC207<br />

Nakuba i-TMC207 isahlolwa,<br />

ulwazi njengamanje<br />

olutholakalayo lube<br />

nomthelela ezigulini eziningi<br />

ezine-TB engazweli emthini<br />

wokuthi ziyafuna ukuwuphuza<br />

lo muthi ukwenza ngcono<br />

ithuba lazo lokuphila<br />

nokunciphisa isikhathi<br />

sokwelashwa. Izishoshovu<br />

zicele i-Tibotec ukuthi lo muthi<br />

iwenze ukuthi utholakale,<br />

kodwa selokhu kungakenzeki.<br />

UKULWA NE- TB<br />

23

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!